Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Vansen Pharma Inc.Financial_Report.xls
EX-31.1 - CERTIFICATION - Vansen Pharma Inc.oknv_ex311.htm
10-K - FORM 10-K - Vansen Pharma Inc.oknv_10k.htm
 
Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
The undersigned, Maria Peralta, President, Chief Executive Officer and Chief Financial Officer of Okana Ventures, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)
the annual report on Form 10-K of Okana Ventures, Inc. for the year ended December 31, 2011 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Okana Ventures, Inc.
 
Dated: March 30, 2012
 
/s/ Maria Peralta                                 
Maria Peralta
President and Treasurer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)